Abstract
Human experimentations refer to medical investigations with humans involved as experimental subjects. These trials are prospective researches aimed at answering specific questions about biomedical interventions, generating safety and efficacy data on drugs and treatments, innovative devices or novel vaccines, as well as new ways of using known interventions.
After a brief introduction of human experimentations, this section presents the main related issues in Law and Economics, i.e., the risk sharing between society and pharmaceutical industry.
References
Criscuolo P (2005) On the road again: researcher mobility inside the R&D network. Res Policy 34:1350–1365
Ippoliti R (2013) The market of human experimentation. Eur J Law Econ 35(1):61–85
LEEM report (2008) L’industrie du médicament en France, réalités économiques Les Entreprises du Médicament (LEEM), 2008 edn, Paris.
The Association of the British Pharmaceutical Industry (1994) Clinical trial compensation guidelines. ABPI, London
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this entry
Cite this entry
Ippoliti, R. (2016). Human Experimentation. In: Marciano, A., Ramello, G. (eds) Encyclopedia of Law and Economics. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7883-6_237-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7883-6_237-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-7883-6
eBook Packages: Springer Reference Economics and FinanceReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences
Publish with us
Chapter history
-
Latest
Human Experimentation- Published:
- 27 July 2021
DOI: https://doi.org/10.1007/978-1-4614-7883-6_237-2
-
Original
Human Experimentation- Published:
- 13 May 2016
DOI: https://doi.org/10.1007/978-1-4614-7883-6_237-1